Gernert, Jonathan A.
Wicklein, Rebecca
Hemmer, Bernhard
Kümpfel, Tania
Knier, Benjamin
Havla, Joachim
Funding for this research was provided by:
Universitätsklinik München
Article History
Received: 1 June 2022
Revised: 8 September 2022
Accepted: 9 September 2022
First Online: 16 October 2022
Declarations
:
: JAG reports no disclosures. RW received a research grant from the medical faculty of the TUM. BH served on scientific advisory boards for Novartis; he has served as DMSC member for AllergyCare, Polpharma, Sandoz; Biocon and TG therapeutics; he or his institution have received speaker honoraria from Desitin; his institution received research grants from Regeneron for MS research. He holds part of two patents, one for the detection of antibodies against KIR4.1 in a subpopulation of patients with MS and one for genetic determinants of neutralizing antibodies to interferon. All conflicts are not relevant to the topic of the study. BH received funding for the study by the European Union’s Horizon 2020 Research and Innovation Program (grant MultipleMS, EU RIA 733161) and the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany’s Excellence Strategy within the framework of the Munich Cluster for Systems Neurology (EXC 2145 SyNergy—ID 390857198). TK has received speaker honoraria and/or personal fees for advisory boards from Bayer Healthcare, Teva Pharma, Merck, Novartis Pharma, Sanofi-Aventis/Genzyme, Roche Pharma and Biogen as well as grant support from Novartis and Chugai Pharma in the past. BK is funded by the Else Kröner-Fresenius Stiftung and the Gemeinnützige Hertie-Stiftung and was awarded with the Oppenheim award granted by Novartis. He received travel support and a research grant from Novartis which are both outside the submitted work. JH reports grants for OCT research from the Friedrich-Baur-Stiftung and Merck, personal fees and non-financial support from Celgene, Janssen, Bayer, Merck, Alexion, Novartis, Roche, Biogen and non-financial support of the Guthy-Jackson Charitable Foundation, all outside the submitted work. JH is partially funded by the German Federal Ministry of Education and Research ((DIFUTURE), Grant Numbers 01ZZ1603[A-D] and 01ZZ1804[A-H]).